Literature DB >> 3050121

Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.

D J Jin1, C A Gross.   

Abstract

Rifampicin is an antibiotic that inhibits the function of RNA polymerase in eubacteria. Mutations affecting the beta subunit of RNA polymerase can confer resistance to rifampicin. A large number of rifampicin-resistant (hereafter called Rifr) mutants have been isolated in Escherichia coli to probe the involvement of RNA polymerase in a variety of physiological processes. We have undertaken a comprehensive analysis of Rifr mutations to identify their structural and functional effects on RNA polymerase. Forty-two Rifr isolates with a variety of phenotypes were mapped to defined intervals within the rpoB gene using a set of deletions of the rpoB gene. The mutations were sequenced. Seventeen mutational alterations affecting 14 amino acid residues were identified. These alleles are located in three distinct clusters in the center of the rpoB gene. We discuss the implications of our results with regards to the structure of the rifampicin binding site.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050121     DOI: 10.1016/0022-2836(88)90517-7

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  252 in total

1.  A novel role for Escherichia coli endonuclease VIII in prevention of spontaneous G-->T transversions.

Authors:  J O Blaisdell; Z Hatahet; S S Wallace
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

2.  Novel approach for improving the productivity of antibiotic-producing strains by inducing combined resistant mutations.

Authors:  H Hu; K Ochi
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

3.  Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay.

Authors:  K Hirano; C Abe; M Takahashi
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

4.  Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis.

Authors:  P Scarpellini; S Braglia; P Carrera; M Cedri; P Cichero; A Colombo; R Crucianelli; A Gori; M Ferrari; A Lazzarin
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Green fluorescent protein as a marker in Rickettsia typhi transformation.

Authors:  J M Troyer; S Radulovic; A F Azad
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 6.  Molecular techniques in biomedical sciences: a new era in diagnosis of infectious diseases.

Authors:  S Chandwani; A Kaul
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

7.  Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins.

Authors:  M Heep; S Odenbreit; D Beck; J Decker; E Prohaska; U Rieger; N Lehn
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

8.  Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus.

Authors:  T A Wichelhaus; V Schäfer; V Brade; B Böddinghaus
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

9.  RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus.

Authors:  A O'Neill; B Oliva; C Storey; A Hoyle; C Fishwick; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

10.  Natural rifampin resistance in Treponema spp. correlates with presence of N531 in RpoB rif cluster i.

Authors:  L V Stamm; H L Bergen; K A Shangraw
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.